SPDR S&P Biotech ETF (XBI) ETF

Expense Ratio: 0.35% | AUM: 3.12B | Issuer: State Street Global Advisors

XBI Daily Price Range
XBI 52-Week Price Range

XBI - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

XBI has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

XBI - Profile & Info


The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.

Issuer State Street Global Advisors
Expense Ratio 0.35%
Assets Under Management (AUM) 3.12B
Underlying Index S&P Biotechnology Select Industry Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $68.08
Options? Yes
Total Holdings 91

XBI - Top Holdings

Symbol Holding Name % of Total
CLVS Clovis Oncology Inc 3.89%
KITE Kite Pharma Inc 3.59%
INCY Incyte Corp 2.99%
ACAD ACADIA Pharmaceuticals Inc 2.81%
BLUE Bluebird Bio Inc 2.77%
EXEL Exelixis Inc 2.67%
EXAS Exact Sciences Corp 2.67%
ALNY Alnylam Pharmaceuticals Inc 2.53%
AMGN Amgen Inc 2.51%
VRTX Vertex Pharmaceuticals Inc 2.43%
ICPT Intercept Pharmaceuticals Inc 2.34%
TSRO TESARO Inc 2.31%
BMRN BioMarin Pharmaceutical Inc 2.20%
CELG Celgene Corp 2.20%
RARE Ultragenyx Pharmaceutical Inc 2.19%
UTHR United Therapeutics Corp 2.18%
PBYI Puma Biotechnology Inc 2.18%
JUNO Juno Therapeutics Inc 2.13%
ABBV AbbVie Inc 2.13%
REGN Regeneron Pharmaceuticals Inc 2.10%
ALKS Alkermes Plc 2.04%
SGEN Seattle Genetics Inc 2.04%
BIIB Biogen Inc 2.00%
NBIX Neurocrine Biosciences Inc 1.92%
SRPT Sarepta Therapeutics Inc 1.91%
GILD Gilead Sciences Inc 1.85%
ALXN Alexion Pharmaceuticals Inc 1.82%
IONS Ionis Pharmaceuticals Inc. 1.79%
RDUS Radius Health Inc 1.76%
AGIO Agios Pharmaceuticals Inc 1.59%
LGND Ligand Pharmaceuticals Inc 1.59%
MYGN Myriad Genetics Inc 1.52%
PTLA Portola Pharmaceuticals Inc 1.47%
SAGE Sage Therapeutics Inc 1.44%
EGRX Eagle Pharmaceuticals Inc/DE 1.31%
ARRY Array BioPharma Inc 1.30%
ONCE Spark Therapeutics Inc 1.17%
AVXS AveXis Inc. 1.12%
OPK OPKO Health Inc 1.01%
XON Intrexon Corp 0.95%
IRWD Ironwood Pharmaceuticals Inc 0.92%
HALO Halozyme Therapeutics Inc 0.89%
PRTA Prothena Corp. Plc 0.89%
FOLD Amicus Therapeutics Inc 0.75%
ALDR Alder Biopharmaceuticals Inc 0.74%
NVAX Novavax Inc 0.73%
ACOR Acorda Therapeutics Inc 0.71%
FPRX Five Prime Therapeutics Inc 0.63%
SGYP Synergy Pharmaceuticals Inc 0.56%
AMAG AMAG Pharmaceuticals Inc 0.51%
BPMC Blueprint Medicines Corp 0.50%
EBS Emergent BioSolutions Inc 0.46%
ACHN Achillion Pharmaceuticals Inc 0.43%
HRTX Heron Therapeutics Inc 0.42%
XLRN Acceleron Pharma Inc 0.42%
LXRX Lexicon Pharmaceuticals Inc 0.41%
ZIOP ZIOPHARM Oncology Inc 0.41%
VNDA Vanda Pharmaceuticals Inc 0.40%
RGEN Repligen Corp 0.38%
FGEN FibroGen Inc 0.38%
RTRX Retrophin Inc 0.37%
MACK Merrimack Pharmaceuticals Inc 0.36%
CHRS Coherus Biosciences Inc 0.34%
PGNX Progenics Pharmaceuticals Inc 0.34%
INO Inovio Pharmaceuticals Inc 0.32%
AGEN Agenus Inc 0.32%
CLDX Celldex Therapeutics Inc 0.30%
KERX Keryx Biopharmaceuticals Inc 0.29%
MDXG MiMedx Group Inc 0.25%
GHDX Genomic Health Inc 0.24%
MNTA Momenta Pharmaceuticals Inc 0.23%
BCRX BioCryst Pharmaceuticals Inc 0.22%
ENTA Enanta Pharmaceuticals Inc 0.20%
XNCR Xencor Inc 0.20%
INSM Insmed Inc 0.19%
EPZM Epizyme Inc 0.18%
MGNX MacroGenics Inc 0.18%
BIVV Bioverativ Inc. 0.17%
ATRA Atara Biotherapeutics Inc 0.14%
CYTK Cytokinetics Inc 0.14%
GERN Geron Corp 0.13%
OPHT Ophthotech Corp 0.12%
AIMT Aimmune Therapeutics Inc 0.12%
ARNA Arena Pharmaceuticals Inc 0.10%
OTIC Otonomy Inc 0.06%
46729666 SSC GOVERNMENT MM GVXX STIF USD 0.06%
267CVR99 DYAX CORP COMMON STOCK USD 0.02%
AQB AquaBounty Technologies Inc 0.00%
0.00%
Identifier Name 0.00%
CASH_USD U.S. Dollar 0.00%

XBI - News


View All XBI News

XBI - Price/Volume Stats

Current price $68.72
Prev. close $68.16
Day low $68.11
Day high $69.05
52-week high $72.58
52-week low $47.88
Day Volume 2,658,200
Avg. volume 5,244,118
Dividend yield 0.17%

XBI - Recent Returns

1-mo 2.38%
3-mo 11.72%
6-mo 1.46%
1-year 37.56%
3-year 48.35%
5-year 162.97%
YTD 16.13%
2016 -15.45%
2015 13.58%
2014 44.97%
2013 48.39%
2012 32.69%

XBI - Stock Chart


XBI - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
Page generated in 2.7837 seconds.